Alpha 2.0
Login Register
» Articles » PMID: 32059674

Correction To: Predictive Biomarkers and Mechanisms Underlying Resistance to PD1/PD-L1 Blockade Cancer Immunotherapy

Overview
Journal Mol Cancer
Publisher Biomed Central
Specialties Molecular Biology
Oncology
Date 2020 Feb 16
PMID 32059674
Citations 3
Authors
Daixi Ren
Yuze Hua
Boyao Yu
Xin Ye
Ziheng He
Chunwei Li
Jie Wang
Yongzhen Mo
Xiaoxu Wei
Yunhua Chen
Yujuan Zhou
Qianjin Liao
Hui Wang
Bo Xiang
Ming Zhou
Xiaoling Li
Guiyuan Li
Yong Li
Zhaoyang Zeng
Wei Xiong
Affiliations
Soon will be listed here.
Abstract

After publication of the article [1], authors found out that Fig. 1 was inadvertently replaced.

Citing Articles

Analyze the Diversity and Function of Immune Cells in the Tumor Microenvironment From the Perspective of Single-Cell RNA Sequencing.

Ma L, Luan Y, Lu L Cancer Med. 2025; 14(5):e70622.

PMID: 40062730 PMC: 11891933. DOI: 10.1002/cam4.70622.

CD38 symmetric dimethyl site R58 promotes malignant tumor cell immune escape by regulating the cAMP-GSK3β-PD-L1 axis.

Liang L, Yue C, Li W, Tang J, He Q, Zeng F Heliyon. 2024; 10(19):e37958.

PMID: 39386836 PMC: 11462232. DOI: 10.1016/j.heliyon.2024.e37958.

PHF5A is a potential diagnostic, prognostic, and immunological biomarker in pan-cancer.

Ding N, Li M, Zhao X Sci Rep. 2023; 13(1):17521.

PMID: 37845358 PMC: 10579340. DOI: 10.1038/s41598-023-44899-6.

Age-Based Disparities in Metastatic Melanoma Patients Treated in the Immune Checkpoint Inhibitors (ICI) Non-ICI Era: A Population-Based Study.

Safi M, Al-Azab M, Jin C, Trapani D, Baldi S, Adlat S Front Immunol. 2021; 12:609728.

PMID: 34887846 PMC: 8650702. DOI: 10.3389/fimmu.2021.609728.